These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1066183

  • 1. Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation.
    Karp JE, Burke PJ.
    Cancer Res; 1976 Oct; 36(10):3600-3. PubMed ID: 1066183
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
    Burke PJ, Karp JE, Vaughan WP.
    J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
    [Abstract] [Full Text] [Related]

  • 3. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 4. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A, Olofsson T.
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [Abstract] [Full Text] [Related]

  • 5. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
    Karp JE, Burke PJ.
    Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
    [Abstract] [Full Text] [Related]

  • 6. Comparison of tritiated thymidine labeling and suicide indices in acute nonlymphocytic leukemia.
    Preisler H, Shoham D.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3681-4. PubMed ID: 279395
    [Abstract] [Full Text] [Related]

  • 7. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE, Ross DD, Yang W, Tidwell ML, Wei Y, Greer J, Mann DL, Nakanishi T, Wright JJ, Colevas AD.
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [Abstract] [Full Text] [Related]

  • 8. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
    Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS.
    Clin Cancer Res; 2005 Dec 01; 11(23):8403-12. PubMed ID: 16322302
    [Abstract] [Full Text] [Related]

  • 9. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan 01; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 10. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD, Weng LJ, Jones RJ, Cowan K, Zilcha M, Piantadosi S, Burke PJ.
    Clin Cancer Res; 1995 Mar 01; 1(3):295-303. PubMed ID: 9815985
    [Abstract] [Full Text] [Related]

  • 11. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N, Tohda S, Suzuki T, Nagata K, Yamashita Y, Imai Y, Maruyama Y, Tomiyama J.
    Cancer Res; 1990 Dec 01; 50(23):7587-92. PubMed ID: 2253209
    [Abstract] [Full Text] [Related]

  • 12. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP, Peters WG, Willemze R.
    Cancer Res; 1986 Aug 01; 46(8):3825-7. PubMed ID: 3460691
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov 01; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 14. Drug induced host factors which stimulate growth of residual leukemia in Lewis x Brown Norway F1 (LEW-BN) rats.
    Burke PJ, Karp JE, Saylor PL.
    Cancer Res; 1986 Apr 01; 46(4 Pt 1):1813-6. PubMed ID: 3485014
    [Abstract] [Full Text] [Related]

  • 15. 1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapy.
    Harris AL.
    Cancer Res; 1981 Jul 01; 41(7):2977-9. PubMed ID: 6941850
    [No Abstract] [Full Text] [Related]

  • 16. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Hug V, Keating MJ, Chubb S.
    Cancer Res; 1980 Mar 01; 40(3):588-91. PubMed ID: 6937239
    [Abstract] [Full Text] [Related]

  • 17. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Blood; 1987 Apr 01; 69(4):1134-40. PubMed ID: 3470054
    [Abstract] [Full Text] [Related]

  • 18. Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
    Burke PJ, Karp JE, Vaughan WP, Sanford PL.
    Blood Cells; 1982 Apr 01; 8(3):519-33. PubMed ID: 7159763
    [Abstract] [Full Text] [Related]

  • 19. Separation of leukemic cells into proliferative and quiescent subpopulations by centrifugal elutriation.
    Preisler HD, Walczak I, Renick J, Rustum YM.
    Cancer Res; 1977 Nov 01; 37(11):3876-80. PubMed ID: 71201
    [Abstract] [Full Text] [Related]

  • 20. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb 01; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.